生活质量问题。含炔雌醇和屈螺酮的口服避孕药的潜在作用。

Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drospirenone.

作者信息

Dickerson Vivian

机构信息

Department of Obstetrics and Gynecology, University of California Irvine Medical Center, 101 The City Drive, Building 53, Room 215, Orange, CA 92868, USA.

出版信息

J Reprod Med. 2002 Nov;47(11 Suppl):985-93.

PMID:12497673

Abstract

The new combined oral contraceptive containing ethinyl estradiol and drospirenone has the potential for improving a woman's quality of life. Drospirenone's antiandrogenic activity, for example, makes it effective in reducing acne and seborrhea. The majority of reproductive-age women suffer from some degree of premenstrual symptomatology. In some cases, these monthly symptoms are severe enough to negatively impact a woman's quality of life. Drospirenone's antimineralocorticoid activity aids in reducing some of the most bothersome symptoms associated with the premenstrual phase of the menstrual cycle.

摘要

含有炔雌醇和屈螺酮的新型复方口服避孕药有改善女性生活质量的潜力。例如，屈螺酮的抗雄激素活性使其在减少痤疮和脂溢方面有效。大多数育龄女性都有一定程度的经前症状。在某些情况下，这些每月出现的症状严重到足以对女性的生活质量产生负面影响。屈螺酮的抗盐皮质激素活性有助于减轻与月经周期经前期相关的一些最困扰人的症状。